Dr. Kewei Yang, F. Hoffmann-La Roche Ltd. - Qepler Conferences & Summits

Dr. Kewei Yang

Scientist, Late-Stage Pharmaceutical and Process Development,
Pharmaceutical Development & Supplies, PTD Biologics Europe (PTDE-P),
F. Hoffmann-La Roche Ltd.,
Basel, Switzerland
Roche - Doing now what patients need next

Dr. Kewei Yang is working as a pharmaceutical scientist and project leader in F. Hoffmann-La Roche Ltd. in Switzerland since 2014, specializing in the development of parenteral drug products for both small and large molecular, manufacturing process development, as well as device combination products.

Before that he has worked on the development of nano-medicine for parenteral application in Novartis in Switzerland.

Dr. Yang studied pharmaceutical science in Peking University in China and obtained his PhD degree of pharmaceutical technology in Friedlich Schiller University of Jena in Germany. By now he has published dozens of peer-reviewed papers and holds a few patents.

Related Sessions:

Pre-Filled Syringes
Summit 2018

Enhance a fully integrated system approach for developing pre-filled syringes to maintain patient centricity.
  • 31-May-2018
  • Berlin, DE
  • Pharma
Day 1: Thursday 31, May 2018
BLOCK: DEVICES MEET NEXT GENERATION FORMULATIONS.
CASE STUDY: How to prevent needle clogging in PFS by selecting the right needle shield.
  • PFS filled with high concentration biologics products.
  • Phenomenon of clogging in staked-in needle of pre-filled syringe.
  • How to characterize the water vapor transmission rate of rigid needle shield.
  • Impact of storage condition on WVTR and needle clogging.
  • Select the right needle shield to prevent needle clogging.
View Details